Purpose of the development: The drug is intended for treatment of purulent wounds of various etiologies (abscesses, carbuncles, cellulitis, felon, sores, burns ІІІA II-IIIB-raising, "diabetic foot", etc.).

Recommended application field: Medicine.

Advantages over analogues: Highly effective drug.

The development stage readiness: Ready for application

Technical and economic effect: Drug's effectiveness is proved by numerous examples of its application surgeon Kiev (Main Military Clinical Hospital, NMU them. Bogomoltsa), Dnepropetrovsk, Vinnitsa (Regional Cancer Center, VNMU them. Pirogov). A search for partners to establish industrial production Metroksan nanocomposite.

Description of the development:
()
Pharmacotherapeutic group - applicator sorbent with antimicrobial activity. NANOCOMPOSITION Metroksan made in terms of pharmacy approved for use in Ukraine and registered substances (Silix, polymethylsiloxane, decamethoxin, metronidazole). You are developing a modified composition Zinc Metroksan to treat wounds in the second phase of wound healing.

Information about newness of the development:
there are Ukrainian patents -- 1 items

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Licence's sale
Licence's sale
Technological document's sale
Combinated reduction to industrial level
Creation of joint enterprise

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua